Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Support the external data activities related to clinical trials to ensure quality, on-time data management deliverables. Assist with the external data reconciliation of the clinical database against safety data, laboratory data and other third-party data as appropriate. Participate in the review of the clinical trial data in accordance with Data Management Plans (DMP), Edit Check Specifications and/or Data Review Guidelines and raise queries to resolve erroneous, missing, incomplete or implausible data. Collaborate cross-functionally with Clinical Operation, Clinical Development and other teams to support in the data review and query management to ensure that quality standards are achieved. Gain hands-on experience in a regulated biotech/pharmaceutical environment while developing a foundational understanding of the external data systems.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern
Number of Employees
251-500 employees